122 related articles for article (PubMed ID: 24324051)
1. Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?
Moreno MU; San José G; Pejenaute Á; Landecho MF; Díez J; Beloqui Ó; Fortuño A; Zalba G
Hypertension; 2014 Mar; 63(3):468-74. PubMed ID: 24324051
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients.
González A; López B; Martín-Raymondi D; Lozano E; Varo N; Barba J; Serrano M; Díez J
J Hypertens; 2005 Dec; 23(12):2297-304. PubMed ID: 16269972
[TBL] [Abstract][Full Text] [Related]
3. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?
López B; González A; Lasarte JJ; Sarobe P; Borrás F; Díaz A; Barba J; Tomás L; Lozano E; Serrano M; Varo N; Beloqui O; Fortuño MA; Díez J
J Hypertens; 2005 Mar; 23(3):625-32. PubMed ID: 15716706
[TBL] [Abstract][Full Text] [Related]
4. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients.
Ravassa S; Beloqui O; Varo N; Barba J; López B; Beaumont J; Zalba G; Díez J; González A
J Hypertens; 2013 Mar; 31(3):587-94. PubMed ID: 23429662
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension.
Robador PA; Moreno MU; Beloqui O; Varo N; Redón J; Fortuño A; Zalba G; Díez J
J Hypertens; 2010 Nov; 28(11):2219-26. PubMed ID: 20683337
[TBL] [Abstract][Full Text] [Related]
6. Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patients.
Almendral JL; Shick V; Rosendorff C; Atlas SA
J Am Soc Hypertens; 2010; 4(3):135-41. PubMed ID: 20470998
[TBL] [Abstract][Full Text] [Related]
7. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives.
Calls J; Cases A; Lario S; Esforzado N; Paré JC; Azqueta M; Jimenez W; Rivera-Fillat F
J Hum Hypertens; 2000 Jan; 14(1):17-21. PubMed ID: 10673726
[TBL] [Abstract][Full Text] [Related]
9. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
[TBL] [Abstract][Full Text] [Related]
10. Arterial hypertension increases left ventricular mass: role of tight blood pressure control.
Ferrara LA; Vaccaro O; Cardoni O; Mancini M; Zanchetti A
J Hum Hypertens; 2004 Sep; 18(9):637-42. PubMed ID: 15014537
[TBL] [Abstract][Full Text] [Related]
11. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
12. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between left ventricular mass index and NADPH oxidase p22phox in patients with non-valvular chronic heart failure].
Yang S; Yao Z; Li M; You R; Wang A; Zhao H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):142-4. PubMed ID: 23353176
[TBL] [Abstract][Full Text] [Related]
14. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension.
Fortuño A; Oliván S; Beloqui O; San José G; Moreno MU; Díez J; Zalba G
J Hypertens; 2004 Nov; 22(11):2169-75. PubMed ID: 15480102
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients.
Milan A; Caserta MA; Dematteis A; Naso D; Pertusio A; Magnino C; Puglisi E; Rabbia F; Pandian NG; Mulatero P; Veglio F
J Hum Hypertens; 2009 Nov; 23(11):743-50. PubMed ID: 19262581
[TBL] [Abstract][Full Text] [Related]
16. Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy.
Tan HW; Zheng GL; Li L; Wang ZH; Gong HP; Zhang Y; Zhong M; Zhang W
J Hypertens; 2008 Mar; 26(3):553-9. PubMed ID: 18300868
[TBL] [Abstract][Full Text] [Related]
17. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy is associated with increased sirtuin level in newly diagnosed hypertensive patients.
Duman H; Bahçeci I; Çinier G; Duman H; Bakırcı EM; Çetin M
Clin Exp Hypertens; 2019; 41(6):511-515. PubMed ID: 30230925
[No Abstract] [Full Text] [Related]
19. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.
San José G; Fortuño A; Moreno MU; Robador PA; Bidegain J; Varo N; Beloqui O; Díez J; Zalba G
Clin Sci (Lond); 2009 Feb; 116(3):233-40. PubMed ID: 18647135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
